Core Viewpoint - The DRG/DIP concept has seen a significant increase of 5.67%, ranking third among concept sectors, with 21 stocks rising, including a 20% surge in Di'an Diagnostics, and several other stocks reaching their daily limit up [1][2]. Group 1: Market Performance - The DRG/DIP concept sector experienced a net inflow of 350 million yuan, with 14 stocks receiving net inflows, and 7 stocks attracting over 30 million yuan each [2]. - Di'an Diagnostics led the net inflow with 290 million yuan, followed by Jiuyuan Yinhai and Guoxin Health with net inflows of 206 million yuan and 127 million yuan, respectively [2][3]. Group 2: Stock Performance - The top performers in the DRG/DIP concept included: - Di'an Diagnostics with a 20% increase and a turnover rate of 20.80% [3]. - Jiuyuan Yinhai with a 10.02% increase and a turnover rate of 10.61% [3]. - Guoxin Health with a 10.01% increase and a turnover rate of 2.90% [3]. - Other notable stocks include: - Weining Health with a 13.79% increase and a turnover rate of 18.16% [4]. - Jiahe Meikang with an 11.17% increase and a turnover rate of 13.98% [3].

Core Viewpoint - The A-share market showed strong performance with the Shanghai Composite Index surpassing 4100 points, indicating a potential bullish trend in the market [3][11]. Market Performance - The Shanghai Composite Index rose by 0.92% to close at 4120.43, the Shenzhen Component Index increased by 1.15% to 14120.15, the ChiNext Index gained 0.77% to 3327.81, and the Sci-Tech Innovation Board Index surged by 2.09% to 1803.40 [4][3]. - The total trading volume in the Shanghai and Shenzhen markets reached 3.12 trillion yuan, an increase of 322.4 billion yuan compared to the previous trading day, with over 3900 stocks rising and more than a hundred stocks hitting the daily limit for two consecutive days [8]. Sector Performance - AI application themes surged, particularly in the fields of healthcare, film, and short drama games, with stocks like Meian Health, Jiuyuan Yinhai, and Guoxin Health hitting the daily limit [5][6]. - The concept of controllable nuclear fusion continued to perform strongly, with stocks such as Hongxun Technology and Xiamen Tungsten rising by the daily limit [7]. Fund Flow - Major funds saw net inflows in sectors such as non-ferrous metals, media, and home appliances, while there were net outflows in semiconductor, insurance, and electronic components sectors [10]. - Specific stocks that attracted significant net inflows included Liou Co., Jinfa Technology, and Kunlun Wanwei, with inflows of 1.747 billion yuan, 1.663 billion yuan, and 1.369 billion yuan respectively [10]. Institutional Insights - Dexun Securities noted that the Shanghai Composite Index's rise above 4100 points, coupled with increased trading volume, suggests the potential for a comprehensive bull market [11]. - Guojin Securities emphasized the acceleration of the spring market and the importance of AI chain rotation opportunities, while Xiangcai Securities highlighted the recent upward breakout of the Shanghai Composite Index, indicating a possible recovery of the upward trend from the second half of 2025 [13].

Core Viewpoint - JiuYuan YinHai (SZ002777) reached its daily limit on January 9, 2026, with a price of 20.31 yuan, marking a 10.02% increase, and a total market capitalization of 8.291 billion yuan [1] Group 1: Financial Performance - The company completed fundraising project adjustments, permanently supplementing 158 million yuan to its working capital, significantly improving capital efficiency [2] - In Q3 2025, the net profit attributable to shareholders increased by 151.66% year-on-year, while the non-recurring net profit surged by 492.73%, and the net cash flow from operating activities turned positive, improving by 131.24% year-on-year [2] Group 2: Strategic Focus - JiuYuan YinHai is focusing on three strategic directions: healthcare insurance, digital governance, and smart cities, leveraging big data and cloud computing technologies to empower the livelihood sector [2] - The current market shows high interest in digital economy and healthcare informationization, indicating potential growth in the industry [2] Group 3: Research and Development - The company's R&D investment increased by 48.69% year-on-year, indicating a stronger commitment to technological innovation, which will enhance core competitiveness [2] - Two subsidiaries received recognition as high-tech enterprises, allowing them to enjoy a 15% corporate income tax reduction for the next three years, which will improve overall profitability [2] Group 4: Market Dynamics - Technical analysis suggests that if the MACD indicator forms a golden cross and the stock price breaks through significant resistance levels, market confidence in the stock will increase [2] - On the day of the price surge, if there is significant inflow of institutional funds and high net buying amounts, it will drive the stock price up to the limit [2]

Core Viewpoint - The A-share market shows positive momentum with the Shanghai Composite Index above the annual line, indicating a potential bullish trend in the market [1]. Group 1: Market Performance - As of 10:30 AM today, the Shanghai Composite Index is at 4112.37 points, with a gain of 0.72% [1]. - The total trading volume in the A-share market is 14,306.83 billion yuan [1]. Group 2: Stocks Breaking Annual Line - A total of 110 A-shares have surpassed the annual line today, with notable stocks including: - Zhongcheng Technology with a deviation rate of 12.46% and a price increase of 17.30% [1]. - Weining Health with a deviation rate of 10.62% and a price increase of 11.26% [1]. - Yaxin Security with a deviation rate of 8.21% and a price increase of 10.05% [1]. - Other stocks with smaller deviation rates that have just crossed the annual line include: - Fenghuang Optical, Jialiqi, and Jiechengtong [1].

机构持仓方面，截止2025年9月30日，久远银海十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股305.37万股，相比上期减少156.95万股。金鹰科技创新股票A（001167）位居第四大流通 股东，持股300.00万股，为新进股东。南方中证1000ETF（512100）位居第六大流通股东，持股261.78 万股，相比上期减少1.61万股。易方达新常态混合（001184）退出十大流通股东之列。 责任编辑：小浪快报 1月5日，久远银海盘中上涨2.06%，截至13:43，报18.31元/股，成交9938.23万元，换手率1.36%，总市 值74.75亿元。 资金流向方面，主力资金净流入348.60万元，特大单买入845.32万元，占比8.51%，卖出294.23万元，占 比2.96%；大单买入1119.35万元，占比11.26%，卖出1321.84万元，占比13.30%。 截至11月28日，久远银海股东户数5.56万，较上期减少0.93%；人均流通股7280股，较上期增加0.94%。 2025年1月-9月，久远银海实现营业收入6.87亿元，同比增长2.83%；归母净利润4278.91万元，同比增长 ...

证券代码：002777 证券简称：久远银海 公告编号：2025-048 四川久远银海软件股份有限公司 关于募集资金专户完成销户的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记载、误导性 陈述或重大遗漏。 四川久远银海软件股份有限公司（以下简称"公司"）已于近日办理完成了募集资金专项 账户的注销手续，现将具体情况公告如下： 一、募集资金基本情况 经中国证券监督管理委员会《关于核准四川久远银海软件股份有限公司非公开发行股票的 批复》（证监许可【2017】1504 号）核准，公司非公开发行人民币普通股股票（A 股） 12,540,592.00 股，每股面值 1 元，发行价格为人民币 35.72 元/股，募集资金总额为人民币 447,950,000.00 元。扣除承销、保荐及税款等费用后总额为 437,450,000 元，扣除其他发行 费用（律师费用、验资费用、信息披露费用，印花税）后实际募集资金净额人民币 435,863,350.47 元。上述资金到位情况业经立信会计师事务所（特殊普通合伙）验证，并由其出具信会师报字 [2018]第 10044 号验资报告。 二、募集资金存放和管理情况 ...

Group 1 - The company held its second extraordinary general meeting of shareholders on December 29, 2025, with a total of 292 attendees representing 165,084,424 shares, accounting for 40.4390% of the total voting shares [3][5] - The meeting was conducted both in-person and via online voting, with specific time slots designated for each method [4][3] - The resolution to terminate certain fundraising projects and permanently supplement working capital with surplus funds was approved, with 99.5264% of the votes in favor [10][11] Group 2 - The company's wholly-owned subsidiary, Guizhou Jiuyuan Yinhai Software Co., Ltd., was recognized as a high-tech enterprise, which allows it to benefit from a reduced corporate income tax rate of 15% for three years [17] - The company's controlling subsidiary, Sichuan Health Jiuyuan Technology Co., Ltd., also received high-tech enterprise recognition, continuing its eligibility for the same tax benefits [17][18] - The re-recognition of Sichuan Health Company as a high-tech enterprise will not impact its 2025 operational activities, as it has already filed tax returns at the 15% rate for the year [18]

（文章来源：证券日报） 证券日报网讯 12月29日，久远银海发布公告称，公司2025年第二次临时股东会审议通过《关于募集资 金投资项目结项、终止并将节余募集资金永久性补充流动资金的议案》。 ...

格隆汇12月29日丨久远银海(002777.SZ)公布，根据全国高新技术企业认定管理工作领导小组办公室签 发的《对贵州省认定机构2025年认定报备的第一批高新技术企业进行备案的公告》，四川久远银海软件 股份有限公司全资子公司贵州久远银海软件有限公司（简称"贵州银海公司"）通过了高新技术企业的认 定，证书编号：GR202552000042，发证日期：2025年12月2日，有效期三年。贵州银海公司为首次被认 定为高新技术企业。根据国家相关规定，获得高新技术企业认定通过后三年内可享受国家关于高新技术 企业的相关优惠政策，即按15%的税率缴纳企业所得税。 根据全国高新技术企业认定管理工作领导小组办公室签发的《对四川省认定机构2025年认定报备的第三 批高新技术企业进行备案的公告》，公司控股子公司四川健康久远科技有限公司（简称"四川健康公 司"）通过了高新技术企业的认定，证书编号：GR202551001870，发证日期：2025年12月8日，有效期 三年。四川健康公司本次高新技术企业的认定系原高新技术企业证书有效期满后的重新认定。根据国家 相关规定，公司自通过高新技术企业重新认定起连续三年可继续享受国家高新技术企业15 ...

格隆汇12月29日丨久远银海(002777.SZ)公布，根据全国高新技术企业认定管理工作领导小组办公室签 发的《对贵州省认定机构2025年认定报备的第一批高新技术企业进行备案的公告》，四川久远银海软件 股份有限公司全资子公司贵州久远银海软件有限公司（简称"贵州银海公司"）通过了高新技术企业的认 定，证书编号：GR202552000042，发证日期：2025年12月2日，有效期三年。贵州银海公司为首次被认 定为高新技术企业。根据国家相关规定，获得高新技术企业认定通过后三年内可享受国家关于高新技术 企业的相关优惠政策，即按15%的税率缴纳企业所得税。 根据全国高新技术企业认定管理工作领导小组办公室签发的《对四川省认定机构2025年认定报备的第三 批高新技术企业进行备案的公告》，公司控股子公司四川健康久远科技有限公司（简称"四川健康公 司"）通过了高新技术企业的认定，证书编号：GR202551001870，发证日期：2025年12月8日，有效期 三年。四川健康公司本次高新技术企业的认定系原高新技术企业证书有效期满后的重新认定。根据国家 相关规定，公司自通过高新技术企业重新认定起连续三年可继续享受国家高新技术企业15 ...